(19)
(11) EP 4 167 969 A1

(12)

(43) Date of publication:
26.04.2023 Bulletin 2023/17

(21) Application number: 21830086.1

(22) Date of filing: 07.05.2021
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61P 3/10(2006.01)
A61K 31/444(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 3/10; A61K 31/4985; A61K 9/2018; A61K 9/2027; A61K 9/2054; A61K 9/2013
(86) International application number:
PCT/TR2021/050440
(87) International publication number:
WO 2021/262114 (30.12.2021 Gazette 2021/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 23.06.2020 TR 202009724

(71) Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
34460 Sariyer/Istanbul (TR)

(72) Inventors:
  • ATAMAN, Seval
    34460 Sar yer/Istanbul (TR)
  • ULUSOY BOZYEL, Muge
    34460 Sar yer/Istanbul (TR)
  • SUNEL, Fatih
    34460 Sar yer/Istanbul (TR)

(74) Representative: Sevinç, Erkan 
Istanbul Patent A.S. Plaza-33, Büyükdere Cad. No: 33/16 Sisli
34381 Istanbul
34381 Istanbul (TR)

   


(54) AN ORALLY DISINTEGRATING TABLET FORMULATION COMPRISING SITAGLIPTIN